LABCORP HOLDINGS INC. Business Combination, Acquisition Related Costs
LABCORP HOLDINGS INC. (LH) reported Business Combination, Acquisition Related Costs of $43.90 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2019-02-28
- LABCORP HOLDINGS INC. business combination, acquisition related costs for the quarter ending 2017-12-31 was $14.10M, a 2250.00% increase year-over-year.
- LABCORP HOLDINGS INC. business combination, acquisition related costs for the quarter ending 2017-09-30 was $23.20M.
- LABCORP HOLDINGS INC. business combination, acquisition related costs for the quarter ending 2017-06-30 was $5.70M.
- LABCORP HOLDINGS INC. business combination, acquisition related costs for the quarter ending 2017-03-31 was $900.00K.
- LABCORP HOLDINGS INC. business combination, acquisition related costs for fiscal 2017 was $43.90M, a 448.75% increase from fiscal 2016.
- LABCORP HOLDINGS INC. business combination, acquisition related costs for fiscal 2016 was $8.00M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2017-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $37.30M derived: sum of 2 quarters · filed 2018-10-30 | $43.00M derived: sum of 3 quarters · filed 2018-10-30 | $43.90M 10-K · filed 2018-02-27 |
| 2017-09-30 | $23.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $28.90M derived: sum of 2 quarters · filed 2018-10-30 | $29.80M 10-Q · filed 2018-10-30 | $30.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $6.60M 10-Q · filed 2018-07-27 | $7.20M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-03-31 | $900.00K 10-Q · filed 2018-05-01 | $1.50M derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $8.00M 10-K · filed 2019-02-28 | ||
| 2016-09-30 | $7.40M 10-Q · filed 2017-11-02 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $166.00M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $166.00M 10-Q · filed 2015-07-30 | ||
| 2015-03-31 | $166.00M 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |